Bispecific CD3 X CD19 diabody for T cell-mediated lysis of malignant human B cells

International Journal of Cancer

Volumn 77, Issue 5, 1998, Pages 763-772

  Kipriyanov, Sergey M ^a   Moldenhauer, Gerhard ^a   Strauss, Gudrun ^a   Little, Melvyn ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BISPECIFIC ANTIBODY; CD19 ANTIGEN; CD3 ANTIGEN; T LYMPHOCYTE RECEPTOR;

ARTICLE; BURKITT LYMPHOMA; CONTROLLED STUDY; CYTOLYSIS; CYTOTOXICITY; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; MINIMAL RESIDUAL DISEASE; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; RAJI CELL; T CELL LEUKEMIA; T LYMPHOCYTE; TUMOR CELL DESTRUCTION;

AMINO ACID SEQUENCE; ANTIBODIES, BISPECIFIC; ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; ANTIGENS, CD; ANTIGENS, CD3; BASE SEQUENCE; CLONING, MOLECULAR; CYTOTOXICITY, IMMUNOLOGIC; DNA PRIMERS; EPITOPES; ESCHERICHIA COLI; HUMANS; IMMUNOGLOBULIN FRAGMENTS; IMMUNOGLOBULIN VARIABLE REGION; LYMPHOMA, B-CELL; MOLECULAR SEQUENCE DATA; RECOMBINANT PROTEINS; T-LYMPHOCYTES;

EID: 0031852589     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19980831)77:5<763::AID-IJC16>3.0.CO;2-2     Document Type: Article

References (48)

1. ADAIR, J.R., ATHWAL, D.S., BODMER, M., BRIGHT, S.M., COLLINS, A., PULITO, V.L., RAO, P.E., REEDMAN, R., ROTHERMEL, A.L., XU, D., ZIVIN, R.A. and JOLLIFFE, L.K., Humanization of the murine anti-human CD3 monoclonal antibody OKT3. Hum. Antibodies Hybridomas, 5, 41-47 (1994).
2. ANDERSON, P.M., CRIST, W., HASZ, D., CARROLL, A.J., MYERS, D.E. and UCKUN, F.M., G19.4(αCD3) × B43(αCD19) monoclonal antibody heteroconjugate triggers CD19 antigen-specific lysis of t(4;11) acute lymphoblastic leukemia cells by activated CD3 antigen-positive cytotoxic T cells. Blood, 80, 2826-2834 (1992).
3. ATWELL, J.L., PEARCE, L.A., LAH, M., GRUEN, L.C., KORTT, A. and HUDSON, P., Design and expression of a stable bispecific scFv dimer with affinity for both glycophorin and N9 neurominidase. Mol. Immunol., 33, 1301-1312 (1996).
4. BIRD, R.E., HARDMAN, K.D., JACOBSON, J.W., JOHNSON, S., KAUFMAN, B.M., LEE, S.-M., LEE, T., POPE, S.H., RIORDAN, G.S. and WHITLOW, M., Single-chain antigen-binding proteins. Science, 242, 423-426 (1988).
5. BOHLEN, H., HOPFF, T., MANZKE, O., ENGERT, A., KUBE, D., WICKRAMANAYAKE, P.D., DIEHL, V. and TESCH, H., Lysis of malignant B cells from patients with B-chronic lymphocytic leukemia by autologous T cells activated with CD3 × CD 19 bispecific antibodies in combination with bivalent CD28 antibodies. Blood, 82, 1803-1812 (1993).
6. BOLHUIS, R.L.H., HOOGENBOOM, H.R. and GRATAMA, J.W., Targeting of peripheral blood T lymphocytes. Springer Semin. Immunopathol., 18, 211-226 (1996).
7. BRADFORD, M.M., A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem., 72, 248-254 (1976).
8. BREITLING, F., DÜBEL, S., SEEHAUS, T., KLEWINGHAUS, I. and LITTLE, M., A surface expression vector for antibody screening. Gene, 104, 147-153 (1991).
9. BRENNAN, M., DAVIDSON, P.F. and PAULUS, H., Preparation of bispecific antibodies by chemical recombination of monoclonal immunoglobulin G1 fragments. Science, 229, 81-83 (1985).
10. CANEVARI, S. and 17 OTHERS, Regression of advanced ovarian carcinoma by intraperitoneal treatment with autologous T lymphocytes retargeted by a bispecific monoclonal antibody. J. nat. Cancer Inst., 87, 1463-1469 (1995).
11. CARTER, P., RIDGWAY, J. and ZHU, Z., Toward the production of bispecific antibody fragments for clinical applications. J. Hematother., 4, 463-470 (1995).
12. CSÓKA, M., STRAUSS G., DEBATIN, K.-M. and MOLDENHAUER, G., Activation of T cell cytotoxicity against autologous common acute lymphoblastic leukemia (cALL) blasts by CD3 × CD19 bispecific antibody. Leukemia, 10, 1765-1772 (1996).
13. DE PALAZZO, I.G., HOLMES, M., GERCEL-TAYLOR, C. and WEINER. L.M., Antitumor effect of a bispecific antibody targeting CA19-9 antigen and CD16. Cancer Res., 52, 5713-5719 (1992).
14. FANGER, M.W., MORGANELLI, P.M. and GUYRE, P.M., Bispecific antibodies. Crit. Rev. Immunol., 12, 101-124 (1992).
15. GILL, S.C. and VON HIPPEL, P.H., Calculation of protein extinction coefficients from amino acid sequence data. Anal. Biochem., 182, 319-326 (1989).
16. 131I-labeled human growth hormone of high specific radioactivity. J. Biochem., 89, 114-120 (1963).
17. GROSSBARD, M.L., PRESS, O.W., APPELBAUM, F.R., BERNSTEIN, I.D. and NADLER, L.M., Monoclonal antibody-based therapies of leukemia and lymphoma. Blood, 80, 863-878 (1992).
18. GRUBER, M., SCHODIN, B.A., WILSON, E.R. and KRANZ, D.M., Efficient tumor cell lysis mediated by a bispecific single chain antibody expressed in Escherichia coli. J. Immunol., 152, 5368-5374 (1994).
19. HOLLIGER, P., BRISSINCK, J., WILLIAMS, R.L., THIELEMANS, K. and WINTER, G., Specific killing of lymphoma cells by cytotoxic T-cells mediated by a bispecific diabody. Protein Eng., 9, 299-305 (1996).
20. HOLLIGER, P., PROSPERO, T. and WINTER, G., "Diabodies": small bivalent and bispecific antibody fragments. Proc. nat. Acad. Sci. (Wash.), 90, 6444-6448 (1993).
21. HORN, U., STRITTMATTER, W., KREBBER, A., KNUPFER, U., KUJAU, M., WENDEROTH, R., MÜLLER, K., MATZKU, S., PLÜCKTHUN, A. and RIESENBERG, D., High volumetric yields of functional dimeric miniantibodies in Escherichia coli, using an optimized expression vector and high-cell-density fermentation under non-limited growth conditions. Appl. Microbiol. Biotechnol., 46, 524-532 (1996).
22. HUSTON, J.S., MUDGETT HUNTER, M., TAI, M.S., McCARTNEY, J., WARREN, F., HABER, E. and OPPERMANN, H., Protein engineering of single-chain Fv analogs and fusion proteins. Methods Enzymol., 203, 46-88 (1991).
23. JACOBS, N., MAZZONI, A., MEZZANZANICA, D., NEGRI. D.R.M., VALOTA, O., COLNAGHI, M.I., MOUTSCHEN, M.P., BONIVER, J. and CANEVARI, S., Efficiency of T cell triggering by anti-CD3 monoclonal antibodies (mAb) with potential usefulness in bispecific mAb generation. Cancer Immunol. Immunother., 44, 257-264 (1997).
24. KIPRIYANOV, S.M., DÚBEL, S., BREITLING, F., KONTERMANN, R.E. and LITTLE, M., Recombinant single-chain Fv fragments carrying C-terminal cysteine residues: production of bivalent and biotinylated miniantibodies. Mol. Immunol., 31, 1047-1158 (1994).
25. KIPRIYANOV, S.M., KUPRIYANOVA, O.A., LITTLE, M. and MOLDENHAUER, G., Rapid detection of recombinant antibody fragments directed against cell-surface antigens by flow cytometry. J. Immunol. Methods, 196, 51-62 (1996).
26. KIPRIYANOV, S.M., MOLDENHAUER, G. and LITTLE, M., High level production of soluble single chain antibodies in small-scale Escherichia coli cultures. J. Immunol. Methods, 200, 69-77 (1997a).
27. KIPRIYANOV, S.M., MOLDENHAUER, G., MARTIN, A.C., KUPRIYANOVA, O.A. and LITTLE, M., Two amino acid mutations in an anti-human CD3 single chain Fv antibody fragment that affect the yield on bacterial secretion but not the affinity. Protein Eng., 10, 445-453 (1997b).
28. KOSTELNY, S.A., COLE, M.S. and TSO, J.Y., Formation of a bispecific antibody by the use of leucine zippers. J. Immunol., 148, 1547-1553 (1992).
29. KUNG, P.C., GOLSTEIN, G., REINHERZ, E.L. and SCHLOSSMAN, S.F., Monoclonal antibodies defining distinctive human T cell surface antigens. Science, 206, 347-349 (1979).
30. LAEMMLI, U.K., Cleavage of structural proteins during the assembly of the head of the bacteriophage T4. Nature (Lond.), 227, 680-685 (1970).
31. MACK, M., RIETHMÜLLER, G. and KUFER, P., A small bispecific antibody construct expressed as a functional single-chain molecule with high tumor cell cytotoxicity. Proc. nat. Acad. Sci. (Wash.), 92, 7021-7025 (1995).
32. MICHON, J., MOUTEL, S., BARBET, J., ROMET-LEMMONNE, J.-L., DEO, Y.D., FRIDMAN, W.H. and TEILLAUD, J.-L., In vitro killing of neuroblastoma cells by neutrophils derived from granulocyte colony stimulating factor treated cancer patients using an anti-disialoganglioside/anti-FcγRI bispecific antibody. Blood, 86, 1124-1130 (1995).
33. MILSTEIN, C. and CUELLO, A.C., Hybrid hybridomas and their use in immunohistochemistry. Nature (Lond.), 305, 537-540 (1983).
34. NITTA, T., SATO, K., YAGITA, H., OKUMURA, K. and ISHI, S., Preliminary trial of specific targeting therapy against malignant glioma. Lancet, 335, 368-376 (1990).
35. PERISIC, O., WEBB, P.A., HOLLIGER, P., WINTER, G. and WILLIAMS, R.L., Crystal structure of a diabody, a bivalent antibody fragment. Structure, 2, 1217-1226 (1994).
36. PEZZUTTO, A., DÖRKEN, B., RABINOVITCH, P.S., LEBETTER, J.A., MOLDENHAUER, G. and CLARK, E.A., CD19 monoclonal antibody HD37 inhibits anti-immunoglobulin-induced B cell activation and proliferation. J. Immunol., 138, 2793-2799 (1987).
37. SANGER, F., NICKLEN, S. and COULSON, R., DNA sequencing with chain terminating inhibitors. Proc. nat. Acad. Sci. (Wash.), 74, 5463-5467 (1977).
38. SCATCHARD, G., The attractions of proteins for small molecules and ions. Ann. N.Y. Acad. Sci., 51, 660-672 (1949).
39. SCHODIN, B.A. and KRANZ, D.M., Binding affinity and inhibitory properties of a single-chain anti-T cell receptor antibody. J. biol. Chem., 268, 25722-25727 (1993).
40. SCHWINZER, R., FRANKLIN, R.A., DOMENICO, J., RENZ, H. and GELFAND, E. W., Monoclonal antibodies directed to different epitopes in the CD3-TCR complex induce different states of competence in resting human T cells. J. Immunol., 148, 1322-1328 (1992).
41. SHALABY, M.R., SHEPARD, H.M., PRESTA, L., RODRIGUES, M.L., BEVERLEY, P.C., FELDMANN, M. and CARTER, P., Development of humanized bispecific antibodies reactive with cytotoxic lymphocytes and tumor cells overexpressing the HER2 protooncogene. J. exp. Med., 175, 217-225 (1992).
42. 2. J. nat. Cancer Inst., 85, 1003-1004 (1993).
43. TRAUNECKER, A., LANZAVECCHIA, A. and KARJALAINEN, K., Bispecific single chain molecules (Janusins) target cytotoxic lymphocytes on HIV infected cells. EMBO J., 10, 3655-3659 (1991).
44. UCKUN, F.M. and LEDBETTER, J.A., Immunobiologic differences between normal and leukemic human B-cell precursors. Proc. nat. Acad. Sci (Wash.), 85, 8603-8607 (1988).
45. VALITUTTI, S., MÜLLER, S., CELLA, M., PADOVAN, E. and LANZAVECCHIA, A., Serial triggering of many T-cell receptors by a few peptide-MHC complexes. Nature (Lond.), 375, 148-151 (1995).
46. WINTER, G. and MILSTEIN, C., Man-made antibodies. Nature (Lond.), 349, 293-299 (1991).
47. ZHU, Z. and CARTER, P., Identification of heavy chain residues in a humanized anti-CD3 antibody important for efficient antigen binding and T cell activation. J. Immunol., 155, 1903-1910 (1995).
48. ZHU, Z., ZAPATA, G., SHALABY, R., SNEDECOR, B., CHEN, H. and CARTER, P., High level secretion of a humanized bispecific diabody from Escherichia coli. Bio/Technology, 14, 192-196 (1996).